Absci (ABSI) Times Interest Earned (2020 - 2026)
Absci (ABSI) posted Times Interest Earned of -$3.45 for Q1 2026, up 99.68% sequentially from -$1070.4 in Q4 2025, and up 27.9% YoY from -$2.69 in Q1 2025.
Powered by 
Analysis
Absci (ABSI) Times Interest Earned (2020 - 2026) Analysis & Trends
Absci has reported Times Interest Earned for 7 years, with the latest figure at -$3.45 in Q1 2026.
- Quarterly Times Interest Earned rose 27.9% year-over-year to -$3.45 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$13.79 (up 29.28% YoY) and the FY2025 annual result came in at -$1.13, up 18.85% from the prior year.
- Times Interest Earned rose to -$3.45 in Q1 2026 per ABSI's latest filing, from -$1070.4 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$0.42 in Q1 2024 and troughed at -$1070.4 in Q4 2025.
- A 5-year average of -$93.59 and a median of -$4.78 in 2025 frame the typical range for Times Interest Earned.
- The widest YoY moves for Times Interest Earned: up 97.23% in 2022, down 1495.07% in 2022.
- Over 5 years, Times Interest Earned stood at -$36.24 in 2022, then slumped by 316.22% to -$150.85 in 2023, then tumbled by 81.08% to -$273.16 in 2024, then tumbled by 291.86% to -$1070.4 in 2025, then soared by 99.68% to -$3.45 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$3.45, -$1070.4, and -$3.08 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Absci | 1.39 Bn | 1.19 Bn | - | -17,079.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -17,079.00 |
| Mar 31, 2026 | -1,713.67 |
| Dec 31, 2025 | -1,070.38 |
| Sep 30, 2025 | -670.09 |
| Jun 30, 2025 | -560.59 |
| Mar 31, 2025 | -351.00 |
| Dec 31, 2024 | -273.16 |
| Sep 30, 2024 | -222.27 |
| Jun 30, 2024 | -178.14 |
| Mar 31, 2024 | -133.51 |
| Dec 31, 2023 | -121.27 |
| Sep 30, 2023 | -101.76 |
| Jun 30, 2023 | -167.92 |
| Mar 31, 2023 | -76.28 |
| Dec 31, 2022 | -73.49 |
| Sep 30, 2022 | -100.24 |
| Jun 30, 2022 | -136.91 |
| Mar 31, 2022 | -147.71 |
| Dec 31, 2021 | -131.28 |
| Sep 30, 2021 | -27.53 |